Downregulation of the RUNX3 Gene by Promoter Hypermethylation and Hemizygous Deletion in Breast Cancer
Open Access
- 1 January 2007
- journal article
- Published by Korean Academy of Medical Sciences in Journal of Korean Medical Science
- Vol. 22 (Suppl) , S24-S31
Abstract
The RUNX3 gene is regarded as a tumor suppressor gene in many human solid tumors, and its inactivation is believed to be related with solid tumor carcinogenesis. As little information is available about the role of the RUNX3 gene in breast cancer, we investigated the relationship between the RUNX3 gene and breast cancer. We performed reverse transcriptase-polymerases chain reaction (RT-PCR), methylation specific PCR, and bicolor fluorescent in situ hybridization analysis in an effort to reveal related mechanisms. Forty breast tissue samples and 13 cell lines were used in this study. Eighty-five percent of breast cancer tissues showed downregulated RUNX3 gene expression, whereas it was downregulated in only 25% of normal breast tissues by RT-PCR assay. Sixty-seven percent of breast cancer cell lines showed downregulated RUNX3 expression, but the RUNX3 gene was not expressed in two normal breast cell lines. Hypermethylation was observed in 53% of breast cancer tissues and 57% of breast cancer cell lines. Hemizygous deletion was observed in 43% of breast cancer cell lines. Hypermethylation and/or hemizygous deletion was observed in 5 of 7 breast cancer cell lines, and the four of these five examined showed no RUNX3 gene expression. We suggest that various mechanisms, including methylation and hemizygous deletion, could contribute to RUNX3 gene inactivation.Keywords
This publication has 30 references indexed in Scilit:
- Dysregulation of Chondrogenesis in Human Cleidocranial DysplasiaThe American Journal of Human Genetics, 2005
- Hypermethylation of the RUNX3 gene in hepatocellular carcinomaExperimental & Molecular Medicine, 2005
- Loss of RUNX3 Expression Significantly Affects the Clinical Outcome of Gastric Cancer Patients and Its Restoration Causes Drastic Suppression of Tumor Growth and MetastasisCancer Research, 2005
- Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression riskOncogene, 2005
- Expression of RUNX3 protein in human lung adenocarcinoma: Implications for tumor progression and prognosisCancer Science, 2005
- Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancersInternational Journal of Cancer, 2004
- Insertions generating the 5′RUNX1/3′CBFA2T1 gene in acute myeloid leukemia cases show variable breakpointsGenes, Chromosomes and Cancer, 2004
- Frequent Loss of RUNX3 Expression by Promoter Hypermethylation in Gastric CarcinomaPathobiology, 2004
- RUNX3 expression in primary and metastatic pancreatic cancerJournal of Clinical Pathology, 2004
- Differential Requirements for Runx Proteins in CD4 Repression and Epigenetic Silencing during T Lymphocyte DevelopmentCell, 2002